Bremelanotide for Hypoactive Sexual Desire Disorder: Contraceptive Subgroups Efficacy Analysis

被引：0

作者：

Clayton, Anita ^{[6
]}

Kingsberg, Sheryl ^{[5
]}

Simon, James ^{[2
,3
]}

Jordan, Robert ^{[4
]}

Williams, Laura ^{[1
]}

Krop, Julie ^{[1
]}

机构：

[1] AMAG Pharmaceut Inc, Waltham, MA USA

[2] George Washington Univ, Washington, DC USA

[3] IntimMed Specialists, Washington, DC USA

[4] Palatin Technol Inc, Cranbury, NJ USA

[5] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA

[6] Univ Virginia, Charlottesville, VA USA

来源：

JOURNAL OF WOMENS HEALTH | 2019年 / 28卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：8 / 8

页数：1

共 50 条

[21] BREMELANOTIDE (BMT) FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN THE RECONNECT STUDY: EFFICACY ANALYSES IN STUDY COMPLETERS AND RESPONDERS
Simon, J.
Portman, D.
Kingsberg, S.
Clayton, A.
Jordan, R.
Lucas, J.
Spana, C.
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (06): : E356 - E357
[22] BREMELANOTIDE PROVIDES MEANINGFUL TREATMENT BENEFITS FOR PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER
Koochaki, P. E.
Revicki, D. A.
Wilson, H.
Pokrzywinski, R.
Jordan, R.
Lucas, J.
JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S126 - S126
[23] WOMEN'S EXPERIENCES WITH BREMELANOTIDE ADMINISTERED, ON DEMAND, FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER
Koochaki, P.
Revicki, D.
Wilson, H.
Pokrzywinski, R.
Jordan, R.
Lucas, J.
JOURNAL OF SEXUAL MEDICINE, 2019, 16 (06): : S30 - S30
[24] Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder Two Randomized Phase 3 Trials
Kingsberg, Sheryl A.
Clayton, Anita H.
Portman, David
Williams, Laura A.
Krop, Julie
Jordan, Robert
Lucas, Johna
Simon, James A.
OBSTETRICS AND GYNECOLOGY, 2019, 134 (05): : 899 - 908
[25] BREMELANOTIDE TREATMENT PROVIDED CLINICALLY MEANINGFUL BENEFITS IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER
Kingsberg, S.
Clayton, A.
Portman, D.
Jordan, R.
Revicki, D.
Williams, L.
Krop, J.
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (07): : S6 - S6
[26] BREMELANOTIDE TREATMENT PROVIDED CLINICALLY MEANINGFUL BENEFITS IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER
Kingsberg, Sheryl
Clayton, Anita
Portman, David
Jordan, Robert
Revicki, Dennis
Williams, Laura
Krop, Julie
JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S46 - S46
[27] BREMELANOTIDE TREATMENT PROVIDED CLINICALLY MEANINGFUL BENEFITS IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER
Kingsberg, S.
Clayton, A.
Portman, D.
Jordan, R.
Revicki, D.
Williams, L.
Krop, J.
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01): : S9 - S10
[28] CONVERSATIONS WITH PARTICIPANTS IN THE RECONNECT STUDIES ABOUT THEIR EXPERIENCES WITH BREMELANOTIDE FOR TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER
Koochaki, P.
Revicki, D.
Wilson, H.
Pokrzywinsiki, R.
Jordan, R.
Lucas, J.
Williams, L.
Krop, J.
JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S75 - S75
[29] Hypoactive sexual desire disorder
Przybylski, Marcin
Spaczynski, Marek
GINEKOLOGIA POLSKA, 2009, 80 (07) : 518 - 522
[30] Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women
Spielmans, Glen I.
JOURNAL OF SEX RESEARCH, 2021, 58 (09) : 1085 - 1105

← 1 2 3 4 5 →